Organisation paid for research Program year 2025 Source: CMS Open Payments

KMI Diagnostics Inc.

Neither a doctor nor a teaching hospital

Research payments

$322,874

79 payments

Through program year 2025, KMI Diagnostics Inc. is reported as receiving $322,874 in research payments, across 79 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$14,020	5
2024	Research	$53,610	21
2023	Research	$44,850	12
2022	Research	$82,022	21
2021	Research	$28,070	7
2020	Research	$47,988	8
2019	Research	$52,314	5

Breakdown

Who paid Research payments · program years 2019–2025

DiaSorin Inc. $322,874 79 payments

Studies the money was for Research payments · program years 2019–2025

Parvovirus IgM Clinical Study $20,917 1 payment
LIAISON Murex HBV, HIV,HCV $20,197 1 payment
LIAISON QuantiFERON TB $19,342 1 payment
Quantiferon Lyme $12,465 1 payment
SARS-CoV-2 TrimericS IgG Quantiferon Clinical Study $11,535 1 payment
LIAISON PSA II Gen (#311320) Clinical Agreement & Precision Plan/Protocol $11,465 1 payment
LIAISON XS Analyzer Migration (Wave 2) LIAISON BRAHMS PCT II GEN, LIAISON TSH, LIAISON FT3, LIAISON FT4, LIAISON T3, & LIAISON T4 $11,460 1 payment
LymeDetect 2022 Clinical Study $10,795 2 payments
VZV IgG HT Clinical Study $10,735 2 payments
MeMed Clinical Study $9,405 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.